Dexcom Promotes Jereme Sylvain to EVP, Chief Operating Officer and CFO

Executive Appointment Summary

On September 10, 2026, the Board of Directors of DexCom, Inc. appointed Jereme Sylvain, the Company's Executive Vice President and Chief Financial Officer, to the expanded dual role of Executive Vice President, Chief Operating Officer and Chief Financial Officer, effective September 14, 2026.

Compensation and Agreement Terms

In connection with his promotion, Mr. Sylvain entered into an offer letter on September 11, 2026, outlining the following terms:

• Annual Base Salary: $767,000
• Target Annual Bonus: 75% of annual base salary
• Equity & Severance Participation: Continues eligibility for annual equity awards under the Amended and Restated 2015 Equity Incentive Plan and participation in the Amended and Restated Severance & Change in Control Plan as an executive officer.

Strategic & Operational Impact

Mr. Sylvain has been with Dexcom since 2018 and has served as CFO since 2021. In this expanded capacity, he takes on oversight of global operations and quality teams in addition to finance functions, aiming to drive greater cross-functional alignment, operational discipline, and scalability across Dexcom's biosensing operations.